Stockrabit · Analysts
Questions across 12 calls

Rishi Mody

Marcellus Investment Managers

Max Healthcare Institute Limited

Max Healthcare Institute Limited CC-Mar25.pdf · 2025-05-21
Yes. So Abhay, I am just looking at your capacity beds, it's around 5,100 beds. And our operational bed count is around 4,654 beds, which comes to a ratio of 90% operationalization. This has been the ratio for the last couple of quarters. Just wanted to understand, historically, we used to do around 95% of our capacity beds were operationalized. Are we going to get to that 95%? Or is it like there's a theoretical capacity, but we are using the space for something else and hence the operational bed count on the existing infrastructure will remain the same?
Okay. Got it. So like in practicality, if the demand is there, y ou can open up 5,100 beds?
Max Healthcare Institute Limited CC-Jun24.pdf · 2024-08-02
Abhay, just on the Mohali hospital that you are planning to add four years out, right, is this going to be firstly an O&M agreement the way we have with Devki Devi and those kinds of hospitals or is it an outright rental sort of a model that we see in retail where we don't incur any CAPEX, we have to just put in a security deposit, and we start operating on it?
So, just from a broader conceptual point of view, right, are we seeing incremental interest from, say, the builder or real estate community towards having this sort of models or like if you could just share your observations from across north India or rest of the country?

Page Industries Limited

Page Industries Limited CC-Mar25.pdf · 2025-05-15
The first thing I want to understand is your q-comm /e-comm space. So under the assumption that it's growing faster than the rest of the channels for us. And basis my understanding of the FMCG industry, it seems that the q -comm channel is a very high gross margin channel for the company, higher than the othe r channels because of the right pack side or something on those lines. So I'm just understanding, is that the case for you guys? And is that playing into the gross margin expansion that you are seeing?
Okay. Just a follow -up there. What I'm seeing till at least a couple of quarters back was that I think Jockey was the only listed player on Blinkit or Zepto. But recently, a lot of these other players have also started getting the listing like X, Y, Z, these other new age brands, Van Heusen and all. So just to understand are you seeing higher competition and at, say, older dark store where you were dominant, are you losing shelf space or losing share of sales even if you are losing shelf space?

Vijaya Diagnostic Centre Limited

Vijaya Diagnostic Centre Limited CC-Dec24.pdf · 2025-02-12
So, first, I wanted to understand, you mentioned that the Tirupat hi hub, you all have put up a PET-CT, which is on a pay-per-use model. Now is this something which is new to the industry where these OEMs are offering a pay-per-use model or like and secondly, if it's something which has been started up, is it available to every player, say, a new player who comes in or it's people who have achieved a certain scale or something on those lines? If you just help me understand?
Second, I wanted to understand, today, like if I look at your FY '25 costs, right, given that we've done decent double-digit SSG on your centers, normally, when we look at other, say, fixed cost businesses, largely fixed cost businesses, there's a decent operating leverage that comes through when you have such high SSGs, which has not been the case here for us. We've done like 30 bps, 40 bps for the full year in terms of EBITDA margin expansion. So just wanted to understand, is there some are there some costs which have been upfront here or is there something where our inefficient and hence, going forward we'll be looking at improving the cost structures?
Vijaya Diagnostic Centre Limited CC-Sep24.pdf · 2024-11-07
So just on the gross margin front, right, we've seen a dip in this quarter. Is it something structural? Like is it a one-off? Or because normally, what we've seen in other diagnostic companies will start as your packages business increases, your gross margin is increasing for at least the PAT players. So just wanted to understand, is that not the case for us?
Okay. So I just wanted to follow up there because Dr. Lal in the recent call, right, they said that their packages business has become gross margin accretive for them. We have been expanding the gross margins for the last few quarters. So just I know you're saying that the packages business is gross margin dilutive. So just wanted to understand where is the gap in my understanding?
Vijaya Diagnostic Centre Limited CC-Jun24.pdf · 2024-08-06
So just wanted to understand on the PH thing, right? We've changed the bra nd name now to Vijaya PH. Has that adversely impacted us or we're not seeing any impact because of the brand change?
So if we were to compare PH's revenue in this quarter versus in the last year same quarter, what has been the growth rate? Like if you want to split it, say, June, how much was the decline, or flattish; and then May and June, what wa s the pickup; April, what was the hit; and then July, what has continued? If you can just give an understanding of how PH is shaping up?

Varun Beverages Limited

Varun Beverages Limited CC-Mar25.pdf · 2025-04-30
So, I heard you saying that Coca Cola has also grown healthily in Q1 CY25 and it's been almost getting 6 years since we acquired the south and west business, little more than 6 years if I am not wrong. So just wanted to understand how is our growth in the south and west India? Are we gaining market share or are we still at the same market share levels that we were at the time of acquisition?
All right. Second, I wanted to understand it's been almost little over a year since Campa launched in Tamil Nadu which is a dominant market for Pepsi. They do have more than 10% market share in the region that they have started operations. So just wanted to get your view on what's happening.

Godrej Consumer Products Limited

Grasim Industries Limited

Dr. Lal Path Labs Ltd.